Aurangabad

Applications are invited for pharmacist in online format for Zilla Parishad Aurangabad. Application in any other format will not be accepted.

Post: Pharmacist - 2 posts

Applications are invited through MKCL for filling up applications from eligible candidates for post of pharmacist

Post: Pharmacists

[adsense:336x280:8701650588]

About Author:
Renuka G. Hade
Quality Assurance Department, Wockhardt Limited,
Aurangabad (431210), M.S.
renukahade@gmail.com

Abstract:
Aripiprazole is a new antipsychotic agent. There is presently no evidence to suggest that it is more effective than existing antipsychotics in the treatment of schizophrenia but it offers prescribers another treatment option for this illness. Its efficacy in treatment-resistant schizophrenia is not established; for these patients clozapine is generally considered the drug of choice.
Aripiprazole is a widely used antipsychotic drug supplied in various dosage forms of Aripiprazole Tablets, Aripiprazole Orodispersible tablets and Aripiprazole Oral solution. These formulations are approved by United States Food and Drug Administartion (USFDA) and European Medicinal Agency (EMA) under the brand name Abilify®, manufactured by Otsuka Pharmaceuticals Limited.¹
Based upon the current market demands of the Aripiprazole worldwide, a complete review of the non-clinical (Animal) safety (toxicological studies), is of considerable importance.

Leading for Pharma Company

Post: Area Sales Manager - 5

[adsense:336x280:8701650588]

State Health Society invites applications for filling vacant positions in district level

Post: Pharmacists

[adsense:336x280:8701650588]

Mylan is one of the world’s leading generics and specialty pharmaceutical companies, providing products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline.

Shreya Group has interests in both pharmaceutical and biopharmaceutical products in key therapeutic segments. Currently, Shreya operates in Russia, CIS, India, South East Asia and African countries. The Group turnover for the year 2006 was US $ 581 million including US $ 85 million in India.